The research results of CC pretreatment in 8 groups of PCOS patients in this article all indicate that the AMH levels have a short-term reduction after using CC, and it is more obvious in non-obese patients, so we can assume that thinner people represent better sensitivity to CC responses. Here, AMH is linked to polycystic ovary syndrome.